Therapy | Page 171 of 190 | SpiritIndia.com

Pancreatic Cancer :: Cytokeratin 20 Expression Linked to Poor Survival

According to an early on-line article published in the journal Cancer, strong expression of the protein cytokeratin 20 in pancreatic cancer is associated with significantly worse survival than low levels or no expression of cytokeratin 20. Patients diagnosed with pancreatic cancer who have a strong cytokeratin 20 expression may wish to undergo more aggressive therapy or participate in a clinical trial to improve their outcomes.

Breast Cancer :: Optimal Radiation Therapy Improves Breast Cancer Survival

Among breast cancer patients who have undergone mastectomy, adjuvant radiation therapy improves survival. However, there is only a survival benefit when the dose is appropriate and the target area is sufficient. These results were published in the Journal of the National Cancer Institute.

Melanoma :: Paclitaxel plus Carboplatin benefits some patients with Melanoma

According to a study published in the journal Cancer, second-line treatment (treatment given when initial treatment doesn’t work) with the chemotherapy drugs paclitaxel and carboplatin resulted in a partial reduction of cancer or stable disease in 45% of patients with metastatic melanoma.

Lung Cancer :: Hormone replacement therapy and decreased survival in women

According to a recent article published in the Journal of Clinical Oncology, women with lung cancer who have taken hormone replacement therapy (HRT) may have a significantly poorer overall survival than those who have never taken HRT.

Leukemia :: Older AML patients do not benefit from more therapy

According to results presented at the 47th annual meeting of the American Society of Hematology (ASH), patients 60 years of age and over diagnosed with acute myeloid leukemia (AML) do not benefit from increased doses of the commonly used chemotherapy agents daunorubicin (Cerubidine?) or cytarabine (Cytosar-U?); as well, increasing the number of treatment courses of subsequent chemotherapy does not provide benefit.

Back Pain :: Surgical Options For Back Pain Sufferers

According to the American Association of Neurological Surgeons (AANS) between 75 and 85 percent of all Americans will suffer from low back pain at some point in their lives. However lumbar fusion is proving to be highly effective for the 10 percent of patients who require surgery.

Homeopathy :: Arndt Schultz Law and its applications in Homoeopathy

According to the Arndt Schultz Law, substances vary in action depending on whether the concentration is high, medium, or low. High concentrations kill; medium concentrations suppress or inhibit; and low, or minute concentrations stimulate.

Depression :: Identify Patients With Treatment-Resistant Depression

Initial results of the nation’s largest clinical trial for depression have helped clinicians to track ‘real world’ patients who became symptom-free and to identify those who were resistant to the initial treatment. Participants treated in both medical and specialty mental health care settings experienced a remission of symptoms in 12 to 14 weeks during well-monitored treatment with an antidepressant medication. The study, funded by the National Institutes of Health’s (NIH) National Institute of Mental Health (NIMH), used flexible adjustment of dosages based on quick and easy-to-use clinician ratings of symptoms and patient self-ratings of side effects.

Health :: Revlimid – lenalidomide for Myelodysplastic Syndrome (MDS)

The Food and Drug Administration (FDA) has approved the drug Revlimid (lenalidomide) for the treatment of patients with a subtype of Myelodysplastic Syndrome (MDS). The subtype is MDS patients with deletion 5q cytogenetic abnormality.

Lupus :: Safety of Oral Contraceptives in Women with Lupus

In a major study funded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a part of the National Institutes of Health (NIH), women with either inactive or stable systemic lupus erythematosus (lupus) – a disease in which the body’s immune system mistakenly attacks and damages healthy tissues of the skin, joints and internal organs – were able to take oral contraceptives without increased risk of flares, or periods of increased disease activity, that characterize the disease.